Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
5
×
Tags
drugs
5
×
clinical trials
life sciences
national blog main
biotech
new york blog main
amgen
boston blog main
fda
new york
new york top stories
san diego blog main
san diego top stories
achaogen
adams street partners
akcea therapeutics
alirocumab
alnylam pharmaceuticals
antibiotics
anylam pharmaceuticals
beta lactamase inhibitor
biomedical advanced research and development authority (barda)
boston top stories
calcitonin gene-related peptide
cardiomyopathy
chronic migraine
deals
drug resistance
eli lilly
episodic migraine
evercore isi
evolocumab
flu
hatteras venture partners
heart attack
inclisiran
indiana
indiana blog main
indiana top stories
inotersen
What
drug
5
×
medicines
5
×
new
alnylam
approved
disease
fda
products
year
additional
ago
akcea
amyloidosis
announced
approval
attr
available
bacteria
based
battle
biopharma
business
cholesterol
class
cold
company
contaminated
data
debilitating
decision
developed
efficient
eli
evidence
exited
expanded
fighting
flu
genetic
headache
Language
unset
Current search:
drugs
×
photo
×
medicines
×
drug
×
@bgr.com
2 years ago
New drug recall issued: Stop taking these cold & flu medicines immediately
@xconomy.com
5 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines